Clinical trial

BRCA1/2 and Effect of Mifepristone on the Breast

NCT01898312

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-09-01

PhasePHASE2

Study timeline

Study start (actual)2013-09-01Date precision: month

Registry last updated2022-01-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2unresolved

Interventions

MifepristoneDRUG · verified · RxNorm: mifepristone

Sponsors & collaborators

Karolinska Institutetlead sponsor

Mapped research locations

StockholmSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01898312 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.